Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients

被引:6
作者
Hsu, Chung-Yuan [1 ]
Chiu, Wen-Chan [1 ]
Chen, Jia-Feng [1 ]
Chou, Ching-Lan [1 ]
Su, Yu-Jih [1 ]
Yu, Shan-Fu [1 ]
Cheng, Tien-Tsai [1 ]
机构
[1] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol,Dept Internal Med, Kaohsiung 833, Taiwan
关键词
Hip fracture; Adherence; Specialty; BISPHOSPHONATE THERAPY; SUBSEQUENT FRACTURE; ZOLEDRONIC ACID; DRUG-THERAPY; RISK; MORTALITY; ALENDRONATE; PERSISTENCE; RATES; CARE;
D O I
10.1007/s00774-014-0621-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is poor adherence in the management of osteoporotic fractures. We designed a study to investigate adherence to osteoporotic regimens among osteoporotic hip fracture patients and to analyze the risk factors associated with poor compliance. This retrospective chart-review study was carried out using a database of osteoporotic hip fracture patients at a medical center in Taiwan for the period 2001-2007. Adherence was assessed using compliance and persistence. Compliance was calculated by the medication possession ratio (MPR) and persistence by the time from treatment initiation to discontinuation. The MPR and corresponding risk factors for poor compliance (MPR < 80 %) were evaluated for year 1. The year 2 results were analyzed only for those subjects with good compliance (MPR a parts per thousand yen 80 %) at the end of year 1. There were 366 osteoporotic hip fracture patients (323 women, 43 men) with a mean age of 73.9 +/- A 7.6 years. Of these, 53.8 % had good compliance for year 1 and 68.5 % for year 2. During 2 years of follow-up, the overall persistence ratio was 33.1 %. The risk factor associated with poor compliance in the first year was index prescription by orthopedists [odds ratio (OR) 1.69, 95 % confidence interval (CI) 1.10-2.59]. Subjects with hypertension (OR 0.69, 95 % CI 0.46-0.99) had good compliance. Index prescription by orthopedists (OR 2.44, 95 % CI 1.31-4.51) was the sole risk factor for poor compliance in year 2. In conclusion, although adherence to osteoporotic regimens was sub-optimal in hip fracture patients, the majority of patients' decreased adherence occurred within the first year. Medical specialties showed different adherences in both year 1 and year 2.
引用
收藏
页码:577 / 583
页数:7
相关论文
共 53 条
[1]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[2]   Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women [J].
Bliuc, Dana ;
Nguyen, D. Nguyen ;
Milch, Vivienne E. ;
Nguyen, Tuan V. ;
Eisman, John A. ;
Center, Jacqueline R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (05) :513-521
[3]   Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment [J].
Boudou, L. ;
Gerbay, B. ;
Chopin, F. ;
Ollagnier, E. ;
Collet, P. ;
Thomas, T. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (07) :2099-2106
[4]   Incidence and Mortality of Hip Fractures in the United States [J].
Brauer, Carmen A. ;
Coca-Perraillon, Marcelo ;
Cutler, David M. ;
Rosen, Allison B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (14) :1573-1579
[5]   Comparison of drug adherence rates among patients with seven different medical conditions [J].
Briesacher, Becky A. ;
Andrade, Susan E. ;
Fouayzi, Hassan ;
Chan, Arnold .
PHARMACOTHERAPY, 2008, 28 (04) :437-443
[6]   The impact of compliance with osteoporosis therapy on fracture rates in actual practice [J].
Caro, JJ ;
Ishak, KJ ;
Huybrechts, KF ;
Raggio, G ;
Naujoks, C .
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) :1003-1008
[7]   Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey [J].
Carr, A. J. ;
Thompson, P. W. ;
Cooper, C. .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (11) :1638-1644
[8]   Secondary prevention of osteoporotic fractures-an "OPTIMAL" model of care from Singapore [J].
Chandran, M. ;
Tan, M. Z. W. ;
Cheen, M. ;
Tan, S. B. ;
Leong, M. ;
Lau, T. C. .
OSTEOPOROSIS INTERNATIONAL, 2013, 24 (11) :2809-2817
[9]   Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis [J].
Chesnut, CH ;
Skag, A ;
Christiansen, C ;
Recker, R ;
Stakkestad, JA ;
Hoiseth, A ;
Felsenberg, D ;
Huss, H ;
Gilbride, J ;
Schimmer, RC ;
Delmas, PD .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1241-1249
[10]   High incidence rate of hip fracture in Taiwan: estimated from a nationwide health insurance database [J].
Chie, WC ;
Yang, RS ;
Liu, JP ;
Tsai, KS .
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) :998-1002